Policy & Regulation
Paraza Pharma names new executive vice-president, Development
5 June 2023 -

Paraza Pharma, a Canada based, fully integrated drug discovery organisation, announced on Monday that it has named Edward W (Ted) Marple, AB (Harvard), MBA (Virginia) as its new executive vice-president, Development.

Marple has over 20 years of experience as a senior executive with wide skill sets across clinical development, IP protection, manufacturing, operations, company and product strategy, finance, and commercial partnering/development in the biotechnology and pharmaceutical industry.

Arshad Siddiqui, Ph.D., Paraza founder and CEO, said, 'We are excited to have Ted join Paraza's senior leadership team as we continue to expand our capabilities to better serve our client-partners. Ted's extensive business and commercial expertise will be invaluable to Paraza as we continue to partner with biotechnology and pharmaceutical companies to accelerate research, development and access to new and better treatments for patients.'